🔎 Trials Near Me

Akèy › Kansè selil dendritik plasmacytoïd blastik › Washington

Etid klinik pou Kansè selil dendritik plasmacytoïd blastik nan Washington

4 etid pou Kansè selil dendritik plasmacytoïd blastik ap chèche patisipan nan sit nan Washington.

Vil nan Washington

Tèks ofisyèl etid la (Anglè)

Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Ap rekriteFaz 2
6 Months – 65 Years · Tout sèks · Mizajou Jul 22, 2026 · NCT06013423

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry

  • Seattle Children's Cancer and Blood Disorders Center, Seattle
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jun 5, 2026 · NCT05430971

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Ap rekriteFaz 1
Jiska laj 80 · Tout sèks · Mizajou May 18, 2026 · NCT03326921

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • Seattle Children's Hospital, Seattle
Ap rekriteFaz 1
Laj 1 a 21 · Tout sèks · Mizajou Dec 6, 2024 · NCT05476770

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.